It is time to think about UPC opt-out again: how it is achieved and its strategic implications
Part 2
by multiple authors
Taylor Wessing appoints two new partners in the Netherlands: Eelco Bergsma and Bram Nijhof
by Eelco Bergsma and Bram Nijhof
A new year dawns - four IP trends for 2022
by multiple authors
Taylor Wessing announces a major Unified Patent Court publishing project
by multiple authors
'Femtech' – regulatory considerations
Tasmina Goraya looks at the application of medical device and healthcare law to femtech products and services.
5 of 5 Insights
Advising IP Group on option exercise to accelerate development of first-in-class gene therapy for patients with cystic fibrosis
by Colin McCall and Nabil Asaad, PhD
UK medicines – Is the Northern Ireland Protocol now unsustainable?
Taylor Wessing spearheads launch of new Trans-Pacific intellectual property guide
by multiple authors
